Open an account

Boston Scientific

BSX · NYSE

$45.58+$0.53 (+1.18%)TodayMarket closed ·
Prev close $45.05

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 59,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Employees
59,000
Headquarters
Marlborough, Massachusetts
Listed
May 19, 1992
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
bostonscientific.com

BSX key statistics

Market cap
66.06B
Price-earnings ratio
18.24
Dividend yield
—
Average volume
16.46M
Volume
16.01M
Open price
$45.67
High today
$46.05
Low today
$45.15
52 Week high
$105.65
52 Week low
$41.39

Boston Scientific (BSX) at a glance

Boston Scientific (BSX) last traded at $45.58, with a market cap of 66.06B and a price-to-earnings ratio of 18.24.

Today the stock has traded between $45.15 and $46.05. The current price is 1.0% above the day's low and 1.0% below its high.

Volume so far is 16.01M shares, in line with the average of 16.46M shares a day.

Over the past year Boston Scientific has ranged from $41.39 to $105.65, and now sits 7% of the way up that range.

Boston Scientific met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.86 per share against an estimate of $0.8354.

The average analyst price target is $65.02, 42.6% above the current price, from 26 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

81%of 26 analyst ratings say Buy
  • Buy80.8%
  • Hold19.2%
  • Sell0.0%
Price target · 33 analystsAvg $65.02
Low
$44.44
Now
$45.58
High
$123.90

BSX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 4.3% on average.

  1. Q3 FY24: reported $0.63 per share against an estimate of $0.5928
  2. Q4 FY24: reported $0.70 per share against an estimate of $0.6629
  3. Q1 FY25: reported $0.75 per share against an estimate of $0.6784
  4. Q2 FY25: reported $0.75 per share against an estimate of $0.7318
  5. Q3 FY25: reported $0.75 per share against an estimate of $0.7207
  6. Q4 FY25: reported $0.80 per share against an estimate of $0.7873
  7. Q1 FY26: reported $0.80 per share against an estimate of $0.7945
  8. Q2 FY26: reported $0.86 per share against an estimate of $0.8354

BSX news

  • Press releasePRNewswire

    Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer

  • Vandana Singh

    FDA Flags Boston Scientific Catheter Recall

  • Vandana Singh

    Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack

  • Vandana Singh

    Boston Scientific Recalls Spinal Cord Stimulator Leads Over Fracture Risk

  • Vandana Singh

    Boston Scientific Reports Global Disruption After Cybersecurity Incident

  • Press releasePRNewswire

    Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results

  • Press releasePRNewswire

    Penumbra, Inc. Reports Second Quarter 2026 Financial Results

  • Vandana Singh

    Boston Scientific Cuts Forecast on Product Slowdown and Competition

Similar companies

Companies in the same industry as Boston Scientific

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.